SEC reporting owner
| Reporting owner CIK | 0001279191 |
|---|---|
| Issuers | 7 |
| Qualifying disclosures | 122 |
| Public purchases | 21 |
| Recent-window purchases | 0 |
| Recent-window sales | 0 |
| Last public filing | 2026-08-19 |
| Coverage | verified |
| Publicly available | Trade date | Ticker | Code | Shares | Reported value |
|---|---|---|---|---|---|
| 2026-08-18 | 2026-08-16 | DRMA | A | 170,068 | Not reported |
| 2026-08-18 | 2026-08-16 | DRMA | A | 1,360,544 | Not reported |
| 2026-08-18 | 2026-08-16 | DRMA | A | 170,068 | Not reported |
| 2026-08-18 | 2026-08-16 | DRMA | A | 170,068 | Not reported |
| 2026-08-18 | 2026-08-16 | DRMA | A | 1,360,544 | Not reported |
| 2026-08-18 | 2026-08-16 | DRMA | A | 1,360,544 | Not reported |
| 2026-01-13 | 2026-01-09 | TENX | A | 3,000 | Not reported |
| 2026-01-06 | 2026-01-02 | DRMA | A | 37,500 | Not reported |
| 2025-12-29 | 2025-12-23 | DRMA | A | 122,549 | Not reported |
| 2025-12-29 | 2025-12-23 | DRMA | A | 490,196 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.